{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:19:16Z","timestamp":1783448356478,"version":"3.55.0"},"reference-count":19,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":165,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The prognostic value of primary tumor size in duodenal neuroendocrine neoplasms (dNENs) \u226420 mm remains uncertain. Although size is used to guide management, its independent effect on survival is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and methods<\/jats:title>\n                    <jats:p>We performed a population-based study using the US SEER database (1975\u20132021), including adults with histologically confirmed dNENs \u226420 mm. Disease-specific survival (DSS) was the primary endpoint. Associations between tumor size, stage, lymph-node involvement, and DSS were evaluated using chi-squared tests, logistic regression, Kaplan\u2013Meier curves, and Cox models. Receiver operating characteristic (ROC) analysis identified the optimal size cutoff. Mediation analysis assessed whether stage or grade mediated the size\u2013DSS relationship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 3,515 eligible cases, median age was 65 years, 51% were male, and 89% had well-differentiated NETs. Most tumors were localized (85.2%) and \u226410 mm (74.4%). Median follow-up was 56 months, with 160 disease-specific deaths (4.6%). In univariable analysis, size &amp;gt;10 mm was associated with worse DSS, but the association disappeared after adjustment for grade, stage, and surgery. Grade G3 and advanced stage independently predicted poorer survival, while radical surgery was protective. Larger tumors were more frequently high grade and advanced stage (P &amp;lt; 0.001), and each 1 mm increase raised the odds of nodal metastasis by 12% (OR 1.12). ROC analysis identified a size threshold of 10.5 mm (AUC = 0.74). Stage mediated only \u223c2% of the size\u2013DSS association.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In duodenal NENs \u2264 20 mm, tumor size &amp;gt;10 mm correlates with disease extent but does not independently affect DSS, supporting its role as a stratification marker rather than a prognostic factor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/eo-25-0108","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:43:57Z","timestamp":1768995837000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-15","source":"Crossref","is-referenced-by-count":1,"title":["Primary tumor size as a prognostic factor in duodenal neuroendocrine neoplasms \u226420 mm: a population-based SEER analysis"],"prefix":"10.1530","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3069-7630","authenticated-orcid":true,"given":"Giuseppe","family":"Lamberti","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Panzuto","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rinzivillo","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaminia Benedetta","family":"Zoboli","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Zannini","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Andrini","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Dell\u2019Unto","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Di Pangrazio","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4615-7340","authenticated-orcid":true,"given":"Davide","family":"Campana","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"2026070714081569400_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.15798","article-title":"Epidemiology of neuroendocrine neoplasms in the US","volume":"8","author":"Dasari","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026070714081569400_bib2","article-title":"Controversies in NEN: an ENETS position statement on the endoscopic management of localised gastric, duodenal and rectal neuroendocrine neoplasms","volume":"16","author":"Panzuto","year":"2025","journal-title":"J Neuroendocrinol"},{"key":"2026070714081569400_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13306","article-title":"European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1\u2013G3","volume":"35","author":"Panzuto","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"2026070714081569400_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00535-025-02247-7","article-title":"Prevalence and risk factors for lymph node metastasis in duodenal neuroendocrine tumors: a systematic review and meta-analysis","volume":"60","author":"Ogata","year":"2025","journal-title":"J Gastroenterol"},{"key":"2026070714081569400_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jss.2021.06.085","article-title":"Incidence of lymph node metastases and impact of radical surgery for duodenal neuroendocrine tumors","volume":"268","author":"Fujii","year":"2021","journal-title":"J Surg Res"},{"key":"2026070714081569400_bib6","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/jso.25753","article-title":"Duodenal neuroendocrine tumors: impact of tumor size and total number of lymph nodes examined","volume":"120","author":"Zhang","year":"2019","journal-title":"J Surg Oncol"},{"key":"2026070714081569400_bib7","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1007\/s11605-017-3448-4","article-title":"Duodenal and ampullary carcinoid tumors: size predicts necessity for lymphadenectomy","volume":"21","author":"Dogeas","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"2026070714081569400_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11605-013-2365-4","article-title":"Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of vater: a population-based study","volume":"18","author":"Randle","year":"2014","journal-title":"J Gastrointest Surg"},{"key":"2026070714081569400_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11605-014-2456-x","article-title":"Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors","volume":"18","author":"Untch","year":"2014","journal-title":"J Gastrointest Surg"},{"key":"2026070714081569400_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000444803","article-title":"Four neuroendocrine tumor types and neuroendocrine carcinoma of the duodenum: analysis of 203 cases","volume":"104","author":"Vanoli","year":"2016","journal-title":"Neuroendocrinology"},{"key":"2026070714081569400_bib11","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1245\/s10434-018-6673-5","article-title":"Heterogeneity of duodenal neuroendocrine tumors: an Italian multi-center experience","volume":"25","author":"Massironi","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"2026070714081569400_bib12","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s40618-021-01528-1","article-title":"Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy","volume":"44","author":"Rossi","year":"2021","journal-title":"J Endocrinol Investig"},{"key":"2026070714081569400_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000459619","article-title":"The risk factors for metastasis in non-ampullary duodenal neuroendocrine tumors measuring 20 mm or less in diameter","volume":"95","author":"Hatta","year":"2017","journal-title":"Digestion"},{"key":"2026070714081569400_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jgh3.12718","article-title":"Risk factors for lymph node metastasis and indication of local resection in duodenal neuroendocrine tumors","volume":"6","author":"Nakao","year":"2022","journal-title":"JGH Open"},{"key":"2026070714081569400_bib15","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ejso.2020.01.030","article-title":"Surgical resection for duodenal neuroendocrine neoplasia: outcome, prognostic factors and risk of metastases","volume":"46","author":"Nie\u00dfen","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"2026070714081569400_bib16","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1159\/000511613","article-title":"A \u201cwatch and wait\u201d strategy involving regular endoscopic surveillance is safe for many patients with small sporadic, grade 1, non-ampullary, non-functioning duodenal neuroendocrine tumours","volume":"111","author":"Exarchou","year":"2021","journal-title":"Neuroendocrinology"},{"key":"2026070714081569400_bib17","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1111\/jgh.15586","article-title":"Favorable long-term outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumor","volume":"36","author":"Matsueda","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"2026070714081569400_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.dld.2023.12.015","article-title":"Endoscopic management of gastric, duodenal and rectal NETs: position paper from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Society of Gastroenterology (SIGE), Italian Society of Digestive Endoscopy (SIED)","volume":"56","author":"Panzuto","year":"2024","journal-title":"Dig Liver Dis"},{"key":"2026070714081569400_bib19","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s11605-018-3825-7","article-title":"Outcomes of surgical and endoscopic resection of duodenal neuroendocrine tumours (NETs): a systematic review of the literature","volume":"22","author":"Dasari","year":"2018","journal-title":"J Gastrointest Surg"}],"container-title":["Endocrine Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eo.bioscientifica.com\/view\/journals\/eo\/6\/1\/EO-25-0108.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eo.bioscientifica.com\/downloadpdf\/journals\/eo\/6\/1\/EO-25-0108.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article-pdf\/doi\/10.1530\/EO-25-0108\/505596\/eo-25-0108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article-pdf\/doi\/10.1530\/EO-25-0108\/505596\/eo-25-0108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:08:25Z","timestamp":1783447705000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article\/6\/1\/e250108\/75899\/Primary-tumor-size-as-a-prognostic-factor-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/eo-25-0108","relation":{},"ISSN":["2634-4793"],"issn-type":[{"value":"2634-4793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"e250108"}}